Phase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced Malignancies
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
City of Hope Medical Center
Emory University
Fox Chase Cancer Center
Memorial Sloan Kettering Cancer Center
St. Jude Children's Research Hospital